IQVIA (IQV) revenue breakdown
By segment, Research & Development Solutions is the largest at 55% of fiscal 2025 revenue; Technology & Analytics Solutions grew fastest, 22% a year over 9 years.
By region, Americas is the largest at 47% of fiscal 2025 revenue; Asia-Pacific grew fastest, 11% a year over 9 years.
Revenue by segment
Fiscal years, as IQVIA reports them in its 10-K filings; fiscal 2025 total $16.3B.
| Segments | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & Development Solutions | $4.7B | $5.1B | $5.5B | $5.8B | $5.8B | $7.6B | $7.9B | $8.4B | $8.5B | $8.9B | 55% |
| Technology & Analytics Solutions | $1.1B | $3.7B | $4.1B | $4.5B | $4.9B | $5.5B | $5.7B | $5.9B | $6.2B | $6.6B | 41% |
| Contract Sales & Medical Solutions | $930M | $915M | $810M | $814M | $741M | $784M | $743M | $727M | $718M | $788M | 5% |
Revenue by region
Fiscal years, as IQVIA reports them in its 10-K filings; fiscal 2025 total $16.3B.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas | $3.3B | $4.6B | $5.0B | $5.5B | $5.4B | $6.8B | $7.0B | $7.6B | $7.4B | $7.7B | 47% |
| Europe and Africa | $2.2B | $3.3B | $3.4B | $3.5B | $3.7B | $4.4B | $4.4B | $4.5B | $4.9B | $5.2B | 32% |
| Asia-Pacific | $1.3B | $1.8B | $2.0B | $2.1B | $2.2B | $2.7B | $3.0B | $3.0B | $3.1B | $3.4B | 21% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for IQV.
Open IQV in InvestinglyQuestions
Where does IQVIA make its money?
In fiscal 2025, by segment: Research & Development Solutions $8.9B, Technology & Analytics Solutions $6.6B, Contract Sales & Medical Solutions $788M.
From IQVIA's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.